|
Dr. Fares is a director of Modigene and its Chief Scientific Officer.
Dr. Fares is the head of the Molecular Biology Division, Biochemical Research Unit, Department of Biochemistry and Molecular Genetics at the Carmel medical Center in Haifa, Israel.
While doing postdoctoral work at Washington University (St. Louis, Missouri), Dr. Fares worked with Prof. Irving Boime to develop Modigene's platform technology. Dr. Fares was elected a research member at the Rappaport Institute for Research in Medical Sciences (Technion - Israel Institute of Technology, Bruce Rappaport Faculty of Medicine, 1995-1997).
He is the recipient of several awards, including the prestigious Lindner Prize of the Israel Endocrine Society (2004), and the Shawers Prize of the Israel Endocrine Society (1997).
Dr. Fares is the author of over forty scientific articles and chapters in scientific textbooks.
He is a member of two Israeli organizations: the Israel Endocrine Society and the Israeli Society for Biochemistry and Molecular Biology. In the United States, Dr. Fares is a member of the Clinical Ligand Assay Society (CLAS), and the New York Academy of Sciences.
He is a graduate of the department of pharmacology at the Technion - Israel Institute of Technology (Haifa, Israel). | 